Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
TEROL, M José
KILT, NCT04984837: Study of Lacutamab in Peripheral T-cell Lymphoma KIR3DL2-expressing patients with r/r PTCL Aug 2021 - Aug 2021: KIR3DL2-expressing patients with r/r PTCL	Recruiting	2	56	Europe	Lacutamab, Gemcitabine, Oxaliplatine	The Lymphoma Academic Research Organisation, Innate Pharma	Peripheral T Cell Lymphoma, Relapse/Recurrence	01/25	01/27